NDATOPICALTAPE
Approved
Jul 1969
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
5/8 — Partial
CORDRAN (flurandrenolide) by Almirall is corticosteroid hormone receptor agonists [moa]. Approved for corticosteroid [epc]. First approved in 1969.
Drug data last refreshed 2h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CORDRAN (flurandrenolide) is a topical corticosteroid tape formulation approved in 1969 for inflammatory and pruritic skin conditions. It works by stabilizing cellular and lysosomal membranes to reduce inflammation, itching, and vasodilation. The tape delivery system provides sustained topical exposure for localized dermatological treatment.
$0.003BPart D
LOE ApproachingDeclining
minimal share in corticosteroid tape market
Minimal commercial investment expected as product approaches loss of exclusivity; legacy brand with stable but shrinking patient base.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
CORDRAN offers limited career growth as a legacy dermatological product approaching or at loss of exclusivity. Roles are primarily focused on defending market share, cost management, and regulatory compliance rather than innovation or expansion.
Brand Manager (Specialty Dermatology)Commercial Associate
Worked on CORDRAN at Almirall? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.